MX386787B - Derivados de hexosa, preparación y usos de los mismos. - Google Patents
Derivados de hexosa, preparación y usos de los mismos.Info
- Publication number
- MX386787B MX386787B MX2016011808A MX2016011808A MX386787B MX 386787 B MX386787 B MX 386787B MX 2016011808 A MX2016011808 A MX 2016011808A MX 2016011808 A MX2016011808 A MX 2016011808A MX 386787 B MX386787 B MX 386787B
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- hexose derivatives
- hexose
- derivatives
- ch2c
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Saccharide Compounds (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461953392P | 2014-03-14 | 2014-03-14 | |
| PCT/PT2015/050001 WO2015137838A1 (en) | 2014-03-14 | 2015-03-13 | Hexose derivatives, preparation and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016011808A MX2016011808A (es) | 2017-05-09 |
| MX386787B true MX386787B (es) | 2025-03-19 |
Family
ID=53264710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016011808A MX386787B (es) | 2014-03-14 | 2015-03-13 | Derivados de hexosa, preparación y usos de los mismos. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11708387B2 (https=) |
| EP (1) | EP3116886A1 (https=) |
| JP (2) | JP7067867B2 (https=) |
| KR (3) | KR102651029B1 (https=) |
| CN (2) | CN106573952A (https=) |
| BR (1) | BR112016021231B1 (https=) |
| CA (1) | CA2942635C (https=) |
| IL (1) | IL247531B (https=) |
| MX (1) | MX386787B (https=) |
| RU (1) | RU2731563C2 (https=) |
| SG (2) | SG10201807891UA (https=) |
| WO (1) | WO2015137838A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102651029B1 (ko) * | 2014-03-14 | 2024-03-25 | 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 | 헥소스 유도체, 그의 제제 및 용도 |
| FR3061013B1 (fr) * | 2016-12-22 | 2020-04-17 | Greenpharma | Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique |
| US12098162B2 (en) * | 2017-11-13 | 2024-09-24 | Extremochem, Lda | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules |
| CN116251110B (zh) * | 2022-11-18 | 2025-02-14 | 广东药科大学 | β-D-吡喃葡萄糖基-乳酸及其衍生物在制备治疗代谢性疾病、炎症药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| DE102004031588A1 (de) * | 2004-06-30 | 2006-02-09 | Symrise Gmbh & Co. Kg | Verwendung von Äpfelsäureglucosiden als Geschmacksstoffe |
| PT103442A (pt) * | 2006-02-24 | 2007-08-31 | Stab Vida Investigacao E Servi | Derivados sintéticos de manosil-glicerato para a estabilização e/ou preservação de biomateriais |
| PT103441A (pt) | 2006-02-24 | 2007-08-24 | Stab Vida Investigacao E Servi | Utilização de solutos compatíveis para melhorar o desempenho de técnicas utilizando materiais biológicos imobilizados |
| DE102010038496A1 (de) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilisierte flüssige enzymhaltige Tensidzubereitung |
| DE102011118027A1 (de) * | 2011-09-12 | 2013-03-14 | Henkel Ag & Co. Kgaa | Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente |
| KR102651029B1 (ko) | 2014-03-14 | 2024-03-25 | 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 | 헥소스 유도체, 그의 제제 및 용도 |
| JP2020097767A (ja) | 2018-12-18 | 2020-06-25 | 株式会社東芝 | 表面処理剤、これを用いた積層体、及び無電解めっき製品 |
-
2015
- 2015-03-13 KR KR1020227017066A patent/KR102651029B1/ko active Active
- 2015-03-13 JP JP2016575290A patent/JP7067867B2/ja active Active
- 2015-03-13 KR KR1020247009385A patent/KR102828884B1/ko active Active
- 2015-03-13 US US15/125,522 patent/US11708387B2/en active Active
- 2015-03-13 BR BR112016021231-2A patent/BR112016021231B1/pt active IP Right Grant
- 2015-03-13 KR KR1020167028609A patent/KR102401853B1/ko active Active
- 2015-03-13 SG SG10201807891UA patent/SG10201807891UA/en unknown
- 2015-03-13 MX MX2016011808A patent/MX386787B/es unknown
- 2015-03-13 CA CA2942635A patent/CA2942635C/en active Active
- 2015-03-13 CN CN201580014386.4A patent/CN106573952A/zh active Pending
- 2015-03-13 EP EP15724386.6A patent/EP3116886A1/en active Pending
- 2015-03-13 RU RU2016140337A patent/RU2731563C2/ru active
- 2015-03-13 CN CN202211044372.5A patent/CN115448964A/zh active Pending
- 2015-03-13 WO PCT/PT2015/050001 patent/WO2015137838A1/en not_active Ceased
- 2015-03-13 SG SG11201607530XA patent/SG11201607530XA/en unknown
-
2016
- 2016-08-29 IL IL247531A patent/IL247531B/en active IP Right Grant
-
2020
- 2020-06-04 JP JP2020097767A patent/JP7077361B2/ja active Active
-
2023
- 2023-06-09 US US18/332,157 patent/US12590117B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201607530XA (en) | 2016-10-28 |
| BR112016021231B1 (pt) | 2021-07-27 |
| KR102401853B1 (ko) | 2022-05-25 |
| US12590117B2 (en) | 2026-03-31 |
| JP7077361B2 (ja) | 2022-05-30 |
| US20230357301A1 (en) | 2023-11-09 |
| IL247531A0 (en) | 2016-11-30 |
| CA2942635A1 (en) | 2015-09-17 |
| KR20220153571A (ko) | 2022-11-18 |
| KR20240045328A (ko) | 2024-04-05 |
| JP2017516838A (ja) | 2017-06-22 |
| SG10201807891UA (en) | 2018-10-30 |
| EP3116886A1 (en) | 2017-01-18 |
| US20180170955A1 (en) | 2018-06-21 |
| IL247531B (en) | 2021-04-29 |
| JP2020183383A (ja) | 2020-11-12 |
| CA2942635C (en) | 2022-12-06 |
| RU2016140337A3 (https=) | 2018-10-30 |
| CN106573952A (zh) | 2017-04-19 |
| KR20160145584A (ko) | 2016-12-20 |
| BR112016021231A2 (en) | 2018-07-10 |
| KR102651029B1 (ko) | 2024-03-25 |
| CN115448964A (zh) | 2022-12-09 |
| US11708387B2 (en) | 2023-07-25 |
| KR102828884B1 (ko) | 2025-07-02 |
| JP7067867B2 (ja) | 2022-05-16 |
| MX2016011808A (es) | 2017-05-09 |
| RU2016140337A (ru) | 2018-04-17 |
| RU2731563C2 (ru) | 2020-09-04 |
| WO2015137838A1 (en) | 2015-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20150509A (es) | Derivados de naftiridina utiles como antagonistas de la alfa-v-beta-6 integrina | |
| CR20160119A (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística | |
| BR112017010354B8 (pt) | Compostos de triazolopirimidina, seu uso, e composição farmacêutica | |
| BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
| EA201591632A1 (ru) | Цитотоксические и антимитотические соединения и способы их применения | |
| EA201692219A1 (ru) | Способы получения противовирусных соединений | |
| PH12015502546A1 (en) | 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient | |
| TR201906354T4 (tr) | Bi̇r hareketli̇ mobi̇lya parçasi i̇çi̇n tahri̇k ci̇hazi | |
| CR20150663A (es) | Derivados de diazacarbazol como ligandos de tau para pet | |
| MX364069B (es) | Moduladores de la proteína activadora de 5-lipoxigenasa. | |
| MX382072B (es) | Microemulsiones y sus usos. | |
| MX387483B (es) | Preparación farmacéutica. | |
| MX381970B (es) | Derivado de sulfonamida y composición farmacéutica que contiene el mismo. | |
| EA201591349A1 (ru) | Способ получения вортиоксетина | |
| MX2015016971A (es) | Formulacion que comprende un agente hipolipidemico. | |
| MX2013002948A (es) | Composiciones farmaceuticas y nutraceuticas de acido abscisico. | |
| BR112016011519A8 (pt) | Nanofibras à base de derivados de éster de ácido hialurônico e seu sal, método de síntese de nanofibras, método de fotocura de nanofibras, nanofibras fotocuradas à base de derivados de ácido hialurônico, preparação compreendendo nanofibras fotocuradas | |
| ECSP15050386A (es) | FORMULACIONES ALTERNATIVAS PARA POLIPÉPTIDOS DE FUSIÓN TNFR: Fc | |
| AR095097A1 (es) | Compuestos de fenoxietoxi | |
| MX386787B (es) | Derivados de hexosa, preparación y usos de los mismos. | |
| ECSP16096831A (es) | Derivados de naftiridinadiona | |
| ECSP19013196A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| ECSP17005294A (es) | Composición adhesiva | |
| MX373636B (es) | Compuestos de azetidiniloxifenilpirrolidina. | |
| EA201690621A1 (ru) | Полиэтиленгликольсодержащие композиции |